logo
Select company
Select metric
$ 53.12MShareholders Equity
VS
Market
29
Sector
47
Industry
51
History
14
$ 5.1Close
$ 2.27 - $ 23.23 52-Week Range
Ticker Information

Ticker

KLRS

Company Name

KALARIS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KALARIS THERAPEUTICS INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KLRS - Equity Historical data
DateShareholders Equity
6/30/2025$ 53.12M
3/31/2025$ 63.87M
12/31/2024$ 113.31M
9/30/2024$ 121.12M
6/30/2024$ 120.29M
3/31/2024$ 120.44M
12/31/2023$ 145.78M
9/30/2023$ 195.33M
6/30/2023$ 229.11M
3/31/2023$ 193.53M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

KLRS - Shareholders Equity, Last 5 years

$ 53.12M

Minimum

Jun 30, 2025

$ 373.9M

Maximum

Sep 30, 2020

$ 201.79M

Average

$ 194.43M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384.98M with a standard deviation of $ 549.17M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384.98M
median$ 166.36M
std$ 549.17M